PT731812E - Metodo para isolar poli-beta-1-4-n-acetilglucosamina - Google Patents

Metodo para isolar poli-beta-1-4-n-acetilglucosamina

Info

Publication number
PT731812E
PT731812E PT95904174T PT95904174T PT731812E PT 731812 E PT731812 E PT 731812E PT 95904174 T PT95904174 T PT 95904174T PT 95904174 T PT95904174 T PT 95904174T PT 731812 E PT731812 E PT 731812E
Authority
PT
Portugal
Prior art keywords
glcnac
beta
relates
present
reformulations
Prior art date
Application number
PT95904174T
Other languages
English (en)
Inventor
John N Vournakis
Sergio Finkielsztein
Ernest R Pariser
Mike Helton
Original Assignee
Marinepolymer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinepolymer Tech Inc filed Critical Marinepolymer Tech Inc
Publication of PT731812E publication Critical patent/PT731812E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C12N1/125—Unicellular algae isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/89—Algae ; Processes using algae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
PT95904174T 1993-12-01 1994-12-01 Metodo para isolar poli-beta-1-4-n-acetilglucosamina PT731812E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/160,569 US5622834A (en) 1993-12-01 1993-12-01 Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture

Publications (1)

Publication Number Publication Date
PT731812E true PT731812E (pt) 2004-08-31

Family

ID=22577431

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95904174T PT731812E (pt) 1993-12-01 1994-12-01 Metodo para isolar poli-beta-1-4-n-acetilglucosamina

Country Status (15)

Country Link
US (2) US5622834A (pt)
EP (2) EP1452546A3 (pt)
JP (3) JP3993633B2 (pt)
CN (1) CN1142833B (pt)
AT (1) ATE263785T1 (pt)
AU (1) AU695850B2 (pt)
CA (1) CA2177823C (pt)
DE (1) DE69433692T2 (pt)
DK (1) DK0731812T3 (pt)
ES (1) ES2219659T3 (pt)
IL (1) IL111825A0 (pt)
NZ (1) NZ277662A (pt)
PT (1) PT731812E (pt)
TW (1) TW458987B (pt)
WO (1) WO1995015343A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
JP3690771B2 (ja) * 1997-10-13 2005-08-31 株式会社ノエビア 皮膚外用剤
CN1098354C (zh) * 1998-11-12 2003-01-08 武汉大学 双酶催化法合成1－β－D－呋喃核糖苷－1，2，4－三氮唑－3－甲酰胺
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
JP2001031592A (ja) * 1999-07-16 2001-02-06 Fujibio Co Ltd キチン・キトサンによるハロゲン含有医薬の副作用防止方法及びそのための配合剤
US7041657B2 (en) * 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
TW583190B (en) * 2001-04-04 2004-04-11 Dainichiseika Color Chem Purified chitins and production process thereof
PL196686B1 (pl) * 2002-02-07 2008-01-31 Abbott Lab De Costa Rica Ltd Sposób oczyszczania chitozanu z białek
AU2003303522B2 (en) * 2002-12-31 2009-05-28 Marine Polymer Technologies, Inc. Hemostatic compositions and uses therefor
NZ542501A (en) 2003-02-24 2009-09-25 Marinepolymer Tech Inc Compositions comprising chitin or chitosan and use thereof
CN1232257C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗和控制物理化学因素致非特异性炎症的药物中的应用
EP1635782A1 (de) * 2003-05-24 2006-03-22 JUVENA (International) AG Gewebekulturmedien als bestandteil von kosmetika
AU2004273867B2 (en) 2003-09-12 2011-01-27 Marine Polymer Technologies, Inc. Vascular access preservation in hemodialysis patients
WO2006057308A1 (ja) * 2004-11-25 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. キトサン中のトロポミオシン測定方法
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
JPWO2007046517A1 (ja) * 2005-10-17 2009-04-23 ヤマハ発動機株式会社 βキチンの製造方法
WO2008103345A2 (en) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
NZ599338A (en) 2007-06-27 2013-11-29 Marinepolymer Tech Inc Complexes of il-15 and il-15ralpha and uses thereof
US8486033B2 (en) * 2007-07-18 2013-07-16 Marine Polymer Technologies, Inc. Application of polymeric materials to screens to facilitate hemostasis and wound healing
AU2008275935A1 (en) * 2007-07-18 2009-01-22 Marine Polymer Technologies, Inc. Application of polymeric materials to screens to facilitate hemostasis and wound healing
WO2009132228A1 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Chitosan-containing protective composition
CA2722145A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
CN106046396B (zh) * 2008-04-24 2019-02-22 麦德托尼克公司 可再水化的多糖颗粒和海绵体
JP5833919B2 (ja) * 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド キトサンと酸化多糖とに基づく保護用ゲル
EP2313104B2 (en) * 2008-04-24 2020-08-26 Medtronic, Inc Thiolated chitosan gel
EP2498820B1 (en) 2009-11-13 2019-01-09 University of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (en) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
CN106045588A (zh) 2011-09-14 2016-10-26 诺维信生物农业公司 组合使用脂壳寡糖和/或壳寡糖与解磷微生物促植物生长
CN107258790A (zh) 2011-09-23 2017-10-20 诺维信生物农业公司 用于增强植物生长的壳寡糖和方法
BR112014029752A2 (pt) * 2012-05-30 2017-06-27 Clariant Finance Bvi Ltd uso de n-metil-n-acilglucaminas como estabilizadores de frio em soluções de tensoativos
US9616088B2 (en) 2013-03-13 2017-04-11 Gel-E, Inc. Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
MX2015011418A (es) 2013-03-14 2015-12-16 Marinepolymer Tech Inc Tratamiento de enfermedades con nanofibras de poli-n-acetilglucosamina.
CN104056298B (zh) * 2013-03-18 2017-04-26 李锋 无规共聚物的伤口应用
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
EP3034612A1 (en) 2014-12-16 2016-06-22 Greenaltech, S.L. Chitin and chitosan producing methods
CN114269350B (zh) * 2019-08-14 2024-07-23 林春木 局部止血组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038367A (en) * 1963-05-28 1966-08-10 Beecham Group Ltd Penicillin derivatives
US3988411A (en) * 1974-02-11 1976-10-26 American Cyanamid Company Spinning and shaping poly-(N-acetyl-D-glucosamine)
US3989535A (en) * 1974-02-11 1976-11-02 American Cyanamid Company Solution of poly(N-acetyl-D-glucosamine)
JPS55152705A (en) * 1979-05-18 1980-11-28 Mitsubishi Rayon Co Ltd Preparation of water-soluble alkali chitin
US4378017A (en) * 1980-03-21 1983-03-29 Kureha Kagaku Kogyo Kabushiki Kaisha Composite material of de-N-acetylated chitin and fibrous collagen
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4605623A (en) * 1982-11-08 1986-08-12 Malette William Graham Method of altering growth and development and suppressing contamination microorganisms in cell or tissue culture
EP0171254B1 (en) * 1984-08-03 1991-06-19 Unitika Ltd. Shaped chitin body
JPH0611810B2 (ja) * 1984-08-23 1994-02-16 ユニチカ株式会社 多孔性キチン成形体及びその製造方法
US4895724A (en) * 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
JPS62288602A (ja) * 1986-06-06 1987-12-15 Agency Of Ind Science & Technol キトサン変性物粒子の製造方法
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5093319A (en) * 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
JPH0691819B2 (ja) * 1991-05-27 1994-11-16 工業技術院長 デアセチラーゼの製造方法
US5229123A (en) * 1991-10-09 1993-07-20 Hoffmann-La Roche Inc. Antifungal agents
US5219749A (en) * 1991-10-09 1993-06-15 Institute For Molecular Biology & Biotechnology/Forth Process for isolating and preparing purified chitin deacetylase
IL100096A (en) * 1991-11-20 1996-03-31 Univ Ramot Method for entrapment of active materials in chitosan
AU3065192A (en) * 1991-12-20 1993-07-28 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
US5260002A (en) * 1991-12-23 1993-11-09 Vanderbilt University Method and apparatus for producing uniform polymeric spheres

Also Published As

Publication number Publication date
CA2177823A1 (en) 1995-06-08
TW458987B (en) 2001-10-11
JP2009079223A (ja) 2009-04-16
AU695850B2 (en) 1998-08-27
EP1452546A3 (en) 2004-10-13
NZ277662A (en) 1998-04-27
ATE263785T1 (de) 2004-04-15
JPH09506126A (ja) 1997-06-17
DE69433692T2 (de) 2005-03-10
US5622834A (en) 1997-04-22
CA2177823C (en) 2002-04-30
EP0731812A1 (en) 1996-09-18
ES2219659T3 (es) 2004-12-01
DE69433692D1 (de) 2004-05-13
EP0731812A4 (en) 1997-06-18
AU1296995A (en) 1995-06-19
WO1995015343A1 (en) 1995-06-08
EP1452546A2 (en) 2004-09-01
CN1142833B (zh) 2010-06-02
EP0731812B1 (en) 2004-04-07
DK0731812T3 (da) 2004-08-02
IL111825A0 (en) 1995-01-24
JP3993633B2 (ja) 2007-10-17
CN1142833A (zh) 1997-02-12
JP2004211101A (ja) 2004-07-29
US5623064A (en) 1997-04-22

Similar Documents

Publication Publication Date Title
PT731812E (pt) Metodo para isolar poli-beta-1-4-n-acetilglucosamina
BG103694A (en) Improved method for the preparation and purification of n-alkylated asparginic derivative
ATE321165T1 (de) Funktionelle faserprodukte und verfahren zur herstellung derselben
NO965339D0 (no) Fraksjonerte, polydisperse blandinger
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
KR960701084A (ko) 사람 인터루킨-10의 정제방법(Purification of human interleukin-10)
ATE240348T1 (de) Verfahren zur herstellung eines proteins
Graf et al. The dicyclohexylcarbodiimide-binding protein of the mitochondrial ATPase complex from beef heart. Isolation and amino acid composition
CA2109368A1 (en) A process for the non-ramdom cleavage of starch and the low d. e. starchconversion products produced therby
PT94331A (pt) Processo de preparacao de uma citosina desaminase termicamente estavel
FI922105A0 (fi) Foerfarande foer isolering av faktor viii.
AU8356891A (en) A process for the purification of insulins by chromatography
DK0894091T3 (da) Fremgangsmåde til oprensning af et protein fra en proteinholdig opløsning
DE69308834D1 (de) Verfahren zur herstellung und reinigung von phospholipidmischungen frei von kontaminierenden unkonventionellen viren
ZA971998B (en) Purification method.
BR9303949A (pt) Enzima dDAP processo para remover dipeptidios amino-terminais e processo par isolar a enzima dDAP
ATE167871T1 (de) Verfahren zur herstellung von vancomycin
IT1222427B (it) Procedimento per la purificazione di interferone
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DE69708420D1 (de) Herstellung von gereinigten (Poly)Peptiden
CA2139931A1 (en) Purification of Factor IX
BR9813522A (pt) Processos para separar e purificar apm e metil éster de n-[n-(3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina e para a produção do derivado de apm, apm ou derivado de apm, e, adoçante
AU5024490A (en) Method of recovering purified epi protein from a solution especially a fermentation solution
DE69606959D1 (de) Verfahren zur Herstellung von Plättchen-Faktor-4
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method